Diagnosing fetal chromosomal aneuploidy using massively parallel genomic sequencing
AssigneeThe Chinese University of Hong Kong
InventorsYuk-Ming Dennis Lo, Rossa Wai Kwun Chiu, Kwan Chee Chan
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Chinese University of Hong Kong
InventorsYuk-Ming Dennis Lo, Rossa Wai Kwun Chiu, Kwan Chee Chan
Estimating the term…
Embodiments of this invention provide methods, systems, and apparatus for determining whether a fetal chromosomal aneuploidy exists from a biological sample obtained from a pregnant female. Nucleic acid molecules of the biological sample are sequenced, such that a fraction of the genome is sequenced. Respective amounts of a clinically-relevant chromosome and of background chromosomes are determined from results of the sequencing. A parameter derived from these amounts (e.g. a ratio) is compared to one or more cutoff values, thereby determining a classification of whether a fetal chromosomal aneuploidy exists.
1-23. (canceled)
A method for performing prenatal diagnosis of a fetal chromosomal aneuploidy in a fetus by analyzing a biological sample obtained from a female subject pregnant with the fetus, wherein the biological sample includes nucleic acid molecules from the female subject and from the fetus, the method comprising:
The method of claim 25, wherein the parameter comprises a ratio of the first amount and the second amount.
Dependencies are inferred from the claim text.